Keywords (1)

Academic
Publications
Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population

Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population,10.1002/pros.21207,Prostate,Ilir Agalliu,Suzanne M. Leanza,

Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population   (Citations: 2)
BibTex | RIS | RefWorks Download
Journal: Prostate , 2010
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
    • ...So far, there are thirteen case‐control studies in 11 articles (Wiklund et al. 2004; Agalliu et al. 2010; Robbins et al. 2008; Shea et al. 2008; Shook et al. 2007; Daugherty et al. 2007; Cybulski et al. 2007; Nam et al. 2005; Maier et al. 2005; Wang et al. 2002 ;R okman et al. 2002) involving the role of R462Q polymorphism, and also thirteen studies in 11 articles (Wiklund et al. 2004; Robbins et al. 2008; Shea et al. 2008; Shook et al. ...
    • ...Four studies referred to Gleason score and 3 studies about T stage in 3 different articles (Agalliu et al. 2010; Wang et al. 2002; Nakazato et al. 2003)...
    • ...Agalliu et al. (2010) USA Caucasian 965/1,237 ‐ 0.137 ‐ PB...

    Yuan-Yuan MiLi-Jieet al. An update analysis of two polymorphisms in encoding ribonuclease L gen...

Sort by: